Global Single Nucleotide Polymorphism (SNP) Genotyping Market Research Report 2026(Status and Outlook)

May 2026 | 137 pages | ID: GEFA5B6D9E1CEN
Bosson Research

Abstracts

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.Global Single Nucleotide Polymorphism (SNP) Genotyping key players include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, etc. Global top five players hold a share about 65%. North America is the largest market, with a share about 40%, followed by Europe and Japan, having a total share about 35 percent. In terms of product, the segment includes Transversion, Transition. And in terms of application, the largest application is Diagnostics, followed by Animal, Plant, Research, etc.

The global Single Nucleotide Polymorphism (SNP) Genotyping market size was estimated at USD 24710.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 21.10% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Single Nucleotide Polymorphism (SNP) Genotyping market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Single Nucleotide Polymorphism (SNP) Genotyping market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Single Nucleotide Polymorphism (SNP) Genotyping market.

Global Single Nucleotide Polymorphism (SNP) Genotyping Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Illumina
• Affymetrix
• Applied Biosystems
• Agilent Technologies
• Beckman Coulter
• Roche
• Qiagen
• Luminex Corporation
• Enzo Life Sciences
• Bio-rad
• Sequenom
• Ocimum Biosolutions
• GE Healthcare
• GenScript
• Douglas Scientific
• BGI
• Beijing Sunbiotech
• HuaGene Biotech
• Generay Biotech
• Benegene
• Shanghai Biochip
• GENESKY
• HD Biosciences

Market Segmentation (by Type)

• Transversion
• Transition

Market Segmentation (by Application)

• Diagnostics
• Animal
• Plant
• Research
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Single Nucleotide Polymorphism (SNP) Genotyping Market

Overview of the regional outlook of the Single Nucleotide Polymorphism (SNP) Genotyping Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Single Nucleotide Polymorphism (SNP) Genotyping Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Single Nucleotide Polymorphism (SNP) Genotyping, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Single Nucleotide Polymorphism (SNP) Genotyping
1.2 Key Market Segments
  1.2.1 Single Nucleotide Polymorphism (SNP) Genotyping Segment by Type
  1.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Product Life Cycle
3.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Company (2020-2025)
3.4 Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Situation and Trends
  3.6.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Single Nucleotide Polymorphism (SNP) Genotyping Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING VALUE CHAIN ANALYSIS

4.1 Single Nucleotide Polymorphism (SNP) Genotyping Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Porter's Five Forces Analysis

6 SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market by Type (2020-2025)
6.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (2021-2025)

7 SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (M USD) by Application (2020-2025)
7.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application (2021-2025)

8 SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET SEGMENTATION BY REGION

8.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region
  8.1.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region
  8.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Region
8.2 North America
  8.2.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Spain
8.4 Asia Pacific
  8.4.1 Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Illumina
  9.1.1 Illumina Basic Information
  9.1.2 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.1.4 Illumina SWOT Analysis
  9.1.5 Illumina Business Overview
  9.1.6 Illumina Recent Developments
9.2 Affymetrix
  9.2.1 Affymetrix Basic Information
  9.2.2 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.2.4 Affymetrix SWOT Analysis
  9.2.5 Affymetrix Business Overview
  9.2.6 Affymetrix Recent Developments
9.3 Applied Biosystems
  9.3.1 Applied Biosystems Basic Information
  9.3.2 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.3.4 Applied Biosystems SWOT Analysis
  9.3.5 Applied Biosystems Business Overview
  9.3.6 Applied Biosystems Recent Developments
9.4 Agilent Technologies
  9.4.1 Agilent Technologies Basic Information
  9.4.2 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.4.4 Agilent Technologies Business Overview
  9.4.5 Agilent Technologies Recent Developments
9.5 Beckman Coulter
  9.5.1 Beckman Coulter Basic Information
  9.5.2 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.5.4 Beckman Coulter Business Overview
  9.5.5 Beckman Coulter Recent Developments
9.6 Roche
  9.6.1 Roche Basic Information
  9.6.2 Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.6.4 Roche Business Overview
  9.6.5 Roche Recent Developments
9.7 Qiagen
  9.7.1 Qiagen Basic Information
  9.7.2 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.7.4 Qiagen Business Overview
  9.7.5 Qiagen Recent Developments
9.8 Luminex Corporation
  9.8.1 Luminex Corporation Basic Information
  9.8.2 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.8.4 Luminex Corporation Business Overview
  9.8.5 Luminex Corporation Recent Developments
9.9 Enzo Life Sciences
  9.9.1 Enzo Life Sciences Basic Information
  9.9.2 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.9.4 Enzo Life Sciences Business Overview
  9.9.5 Enzo Life Sciences Recent Developments
9.10 Bio-rad
  9.10.1 Bio-rad Basic Information
  9.10.2 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.10.4 Bio-rad Business Overview
  9.10.5 Bio-rad Recent Developments
9.11 Sequenom
  9.11.1 Sequenom Basic Information
  9.11.2 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.11.4 Sequenom Business Overview
  9.11.5 Sequenom Recent Developments
9.12 Ocimum Biosolutions
  9.12.1 Ocimum Biosolutions Basic Information
  9.12.2 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.12.4 Ocimum Biosolutions Business Overview
  9.12.5 Ocimum Biosolutions Recent Developments
9.13 GE Healthcare
  9.13.1 GE Healthcare Basic Information
  9.13.2 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.13.4 GE Healthcare Business Overview
  9.13.5 GE Healthcare Recent Developments
9.14 GenScript
  9.14.1 GenScript Basic Information
  9.14.2 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.14.4 GenScript Business Overview
  9.14.5 GenScript Recent Developments
9.15 Douglas Scientific
  9.15.1 Douglas Scientific Basic Information
  9.15.2 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.15.4 Douglas Scientific Business Overview
  9.15.5 Douglas Scientific Recent Developments
9.16 BGI
  9.16.1 BGI Basic Information
  9.16.2 BGI Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.16.4 BGI Business Overview
  9.16.5 BGI Recent Developments
9.17 Beijing Sunbiotech
  9.17.1 Beijing Sunbiotech Basic Information
  9.17.2 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.17.4 Beijing Sunbiotech Business Overview
  9.17.5 Beijing Sunbiotech Recent Developments
9.18 HuaGene Biotech
  9.18.1 HuaGene Biotech Basic Information
  9.18.2 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.18.4 HuaGene Biotech Business Overview
  9.18.5 HuaGene Biotech Recent Developments
9.19 Generay Biotech
  9.19.1 Generay Biotech Basic Information
  9.19.2 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.19.4 Generay Biotech Business Overview
  9.19.5 Generay Biotech Recent Developments
9.20 Benegene
  9.20.1 Benegene Basic Information
  9.20.2 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.20.4 Benegene Business Overview
  9.20.5 Benegene Recent Developments
9.21 Shanghai Biochip
  9.21.1 Shanghai Biochip Basic Information
  9.21.2 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.21.4 Shanghai Biochip Business Overview
  9.21.5 Shanghai Biochip Recent Developments
9.22 GENESKY
  9.22.1 GENESKY Basic Information
  9.22.2 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.22.4 GENESKY Business Overview
  9.22.5 GENESKY Recent Developments
9.23 HD Biosciences
  9.23.1 HD Biosciences Basic Information
  9.23.2 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
  9.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
  9.23.4 HD Biosciences Business Overview
  9.23.5 HD Biosciences Recent Developments

10 SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET FORECAST BY REGION

10.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast
10.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country
  10.2.3 Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Region
  10.2.4 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Sales of Single Nucleotide Polymorphism (SNP) Genotyping by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

11.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast by Type (2026-2035)
  11.1.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Type (2026-2035)
11.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast by Application (2026-2035)
  11.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (M USD) Forecast by Application (2026-2035)

12 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (M USD)
Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
Table 5. Single Nucleotide Polymorphism (SNP) Genotyping Market Size Comparison by Region (M USD)
Table 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) by Company (2020-2025)
Table 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Single Nucleotide Polymorphism (SNP) Genotyping Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (M USD)
Table 22. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (M USD) by Type (2020-2025)
Table 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2020-2025)
Table 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (2021-2025)
Table 25. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
Table 26. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2020-2025) & (M USD)
Table 27. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2020-2025)
Table 28. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application (2021-2025)
Table 29. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2020-2025) & (M USD)
Table 30. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Region (2020-2025)
Table 31. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2020-2025) & (M USD)
Table 34. South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2020-2025) & (M USD)
Table 36. Illumina Basic Information
Table 37. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 38. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Illumina SWOT Analysis
Table 40. Illumina Business Overview
Table 41. Illumina Recent Developments
Table 42. Affymetrix Basic Information
Table 43. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 44. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Affymetrix SWOT Analysis
Table 46. Affymetrix Business Overview
Table 47. Affymetrix Recent Developments
Table 48. Applied Biosystems Basic Information
Table 49. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 50. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Applied Biosystems SWOT Analysis
Table 52. Applied Biosystems Business Overview
Table 53. Applied Biosystems Recent Developments
Table 54. Agilent Technologies Basic Information
Table 55. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 56. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Agilent Technologies Business Overview
Table 58. Agilent Technologies Recent Developments
Table 59. Beckman Coulter Basic Information
Table 60. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 61. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Beckman Coulter Business Overview
Table 63. Beckman Coulter Recent Developments
Table 64. Roche Basic Information
Table 65. Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 66. Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Roche Business Overview
Table 68. Roche Recent Developments
Table 69. Qiagen Basic Information
Table 70. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 71. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Qiagen Business Overview
Table 73. Qiagen Recent Developments
Table 74. Luminex Corporation Basic Information
Table 75. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 76. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Luminex Corporation Business Overview
Table 78. Luminex Corporation Recent Developments
Table 79. Enzo Life Sciences Basic Information
Table 80. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 81. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Enzo Life Sciences Business Overview
Table 83. Enzo Life Sciences Recent Developments
Table 84. Bio-rad Basic Information
Table 85. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 86. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Bio-rad Business Overview
Table 88. Bio-rad Recent Developments
Table 89. Sequenom Basic Information
Table 90. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 91. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Sequenom Business Overview
Table 93. Sequenom Recent Developments
Table 94. Ocimum Biosolutions Basic Information
Table 95. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 96. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Ocimum Biosolutions Business Overview
Table 98. Ocimum Biosolutions Recent Developments
Table 99. GE Healthcare Basic Information
Table 100. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 101. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 102. GE Healthcare Business Overview
Table 103. GE Healthcare Recent Developments
Table 104. GenScript Basic Information
Table 105. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 106. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 107. GenScript Business Overview
Table 108. GenScript Recent Developments
Table 109. Douglas Scientific Basic Information
Table 110. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 111. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Douglas Scientific Business Overview
Table 113. Douglas Scientific Recent Developments
Table 114. BGI Basic Information
Table 115. BGI Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 116. BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 117. BGI Business Overview
Table 118. BGI Recent Developments
Table 119. Beijing Sunbiotech Basic Information
Table 120. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 121. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 122. Beijing Sunbiotech Business Overview
Table 123. Beijing Sunbiotech Recent Developments
Table 124. HuaGene Biotech Basic Information
Table 125. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 126. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 127. HuaGene Biotech Business Overview
Table 128. HuaGene Biotech Recent Developments
Table 129. Generay Biotech Basic Information
Table 130. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 131. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 132. Generay Biotech Business Overview
Table 133. Generay Biotech Recent Developments
Table 134. Benegene Basic Information
Table 135. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 136. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 137. Benegene Business Overview
Table 138. Benegene Recent Developments
Table 139. Shanghai Biochip Basic Information
Table 140. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 141. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 142. Shanghai Biochip Business Overview
Table 143. Shanghai Biochip Recent Developments
Table 144. GENESKY Basic Information
Table 145. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 146. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 147. GENESKY Business Overview
Table 148. GENESKY Recent Developments
Table 149. HD Biosciences Basic Information
Table 150. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
Table 151. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue (M USD) and Gross Margin (2020-2025)
Table 152. HD Biosciences Business Overview
Table 153. HD Biosciences Recent Developments
Table 154. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Region (2026-2035) & (M USD)
Table 155. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Type (2026-2035) & (M USD)
Table 161. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Industry Chain of Single Nucleotide Polymorphism (SNP) Genotyping
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (M USD), 2025-2035
Figure 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Single Nucleotide Polymorphism (SNP) Genotyping Product Life Cycle
Figure 12. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Company in 2025
Figure 13. Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2025
Figure 15. Value Chain Map of Single Nucleotide Polymorphism (SNP) Genotyping
Figure 16. Global Single Nucleotide Polymorphism (SNP) Genotyping Market PEST Analysis
Figure 17. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type
Figure 20. Market Share of Single Nucleotide Polymorphism (SNP) Genotyping by Type (2020-2025)
Figure 21. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application
Figure 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2020-2025)
Figure 25. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application in 2024
Figure 26. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Region (2020-2025)
Figure 28. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Country in 2024
Figure 30. U.S. Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Single Nucleotide Polymorphism (SNP) Genotyping Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country in 2024
Figure 35. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Region in 2024
Figure 42. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (M USD)
Figure 48. South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Country in 2024
Figure 49. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share Forecast by Type (2026-2035)
Figure 61. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share Forecast by Application (2026-2035)